Slovenian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
multiple sclerosis/tyrosine
Povezava se shrani v odložišče
10 rezultatov
Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor SAR442168 (PERSEUS)
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Study duration will vary per participant in this event driven trial with a treatment duration of approximately 24 to 48 months.
Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor SAR442168
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Study duration will vary per participant in this event driven trial with a treatment duration of approximately 24 to 48 months.
Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor SAR442168
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Study duration will vary per participant in this event driven trial with a treatment duration of approximately 18 to 36 months.
Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor SAR442168
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Study duration will vary per participant in this event driven trial with a treatment duration of approximately 18 to 36 months.
Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Test plan overview Project phase Phase II
Indication:
Complementary treatment of COVID 19
The purpose of the study:
Examine the efficacy and tolerance of a chlorine dioxide based preparation
Study design:
Quasi-experimental clinical case study
Number of patients expected:
20 patients.
Main inclusion
Dimethylfumarate (DMF) in Relapsed/Refractory CLL/SLL
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
This is a phase I clinical trial to evaluate the safety, tolerability, and maximum tolerated dose of DMF in patients with chronic lymphocytic leukemia. Patients with relapsed/refractory CLL not amenable to available therapies are eligible. This patient population is in need of novel therapies,
Assessing Induction of Type II (M2) Monocytes/Macrophages in Patients Receiving Gilenya.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple Sclerosis
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Masitinib is a selective tyrosine kinase inhibitor that is thought to exert a neuroprotective effect through its activity on mast cells and other non-neuronal cells of the central nervous system, with subsequent modulation of inflammatory and neurodegenerative processes. The objective of this study
The Immune and Clinical Impacts of Vitamin D in Patients With Chronic Musculo-skeletal Pain
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
The immune and clinical impacts of vitamin D in patients with chronic musculo-skeletal pain
Background Vitamin D is a group of fat-soluble secosteroids, the two major physiologically relevant forms are vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol). Vitamin D without a subscript refers
A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid Neoplasms
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Chronic myeloid neoplasms (CMPN) consists of three main entities, polycythemia vera (PV), essential thrombocythemia (ET) and primary myelofibrosis (PMF). These three disorders have many overlapping clinical features. The diseases are clonal stem cell disorders characterized by a chronic excess
Najbolj popolna baza zdravilnih zelišč, podprta z znanostjo
- Deluje v 55 jezikih
- Zeliščna zdravila, podprta z znanostjo
- Prepoznavanje zelišč po sliki
- Interaktivni GPS zemljevid - označite zelišča na lokaciji (kmalu)
- Preberite znanstvene publikacije, povezane z vašim iskanjem
- Iščite zdravilna zelišča po njihovih učinkih
- Organizirajte svoje interese in bodite na tekočem z raziskavami novic, kliničnimi preskušanji in patenti
Vnesite simptom ali bolezen in preberite o zeliščih, ki bi lahko pomagala, vnesite zelišče in si oglejte bolezni in simptome, proti katerim se uporablja.
* Vse informacije temeljijo na objavljenih znanstvenih raziskavah
